The Information on Exposure and Duration of Suffering with Medication Compliance in Patients of Hypertension
Abstract
The successfully of hypertension therapy is long-term blood pressure control. Taking antihypertensive drugs regularly is one way to control blood pressure. However, many hypertensive patients are reluctant to seek treatment and continue taking medication. Some factors associated with this condition are the length of time suffering from hypertension and exposure to information received. The use of drugs for a long time can trigger boredom, while credible information can increase adherence to therapy. This study aims to analyze the relationship between information exposure and duration of hypertension with medication adherence. The subjects of this study were hypertensive patients. The sample size was 320 people who suffered from hypertension for at least six months and were actively treated. The research data were collected with a questionnaire instrument and quota sampling technique. The data were processed with SPSS and presented univariately and bivariately. The correlation test used the Chi-Square test with a significance level of 0.05. The results showed that the majority of respondents were less compliant with taking medication. The correlation test of information exposure and duration of hypertension with medication adherence obtained a p-value of 0.000 for both variables. The test results indicate a relationship between information exposure and duration of hypertension with medication adherence. Hypertensive patients need to get credible information during their therapy. Therefore, it is very important to provide credible information facilities as a means to inform and educate hypertensive patients about the importance of medication adherence to optimize health status.
References
2. Feyissa L, Miressa L. Uncontrolled Hypertension and Associated Factors among Hypertensive Adults in Bale Zone Public Hospitals, Ethiopia. J Hypertens Manag. 2021 Mar 30;7(1):057.
3. Romdhoni A. The Effect of Hypertension on Hearing Sense. Biomol Heal Sci J [Internet]. 2018 May 31 [cited 2021 Sep 9];1(1):69–74.
4. Dai X, Hua L, Chen Y, Wang J, Li J, Wu F, et al. Mechanisms in hypertension and target organ damage: Is the role of the thymus key? (Review). Int J Mol Med [Internet]. 2018 Jul 1 [cited 2021 Sep 9];42(1):3.
5. Elsanti S. Panduan Hidup Sehat Bebas Kolesterol, Stroke, Hipertesi dan Serangan Jantung. Yogyakarta: Araska; 2009.
6. Balitbang Kemenkes Republik Indonesia. Hasil Utama Riset Kesehatan Dasar 2018. Jakarta; 2018.
7. Dinas Kesehatan Provinsi Jawa Tengah. Profil Kesehatan Provinsi Jawa Tengah Tahun 2019 [Internet]. Semarang; 2020 [cited 2021 Sep 9]. Available from: www.dinkesjatengprov.go.id.
8. Lisiswanti R, Nur D, Dananda A. Upaya Pencegahan Hipertensi. J Major [Internet]. 2016 Sep 1 [cited 2022 Jan 27];5(3):50–4.
9. Kementerian Kesehatan Republik Indonesia. Hipertensi Penyakit Paling Banyak Diidap Masyarakat [Internet]. 2019 [cited 2021 Sep 6]. Available from: https://www.kemkes.go.id/article/view/19051700002/hipertensi-penyakit-paling-banyak-diidap-masyarakat.html
10. Darnindro N, Sarwono J. Prevalensi Ketidakpatuhan Kunjungan Kontrol pada Pasien Hipertensi yang Berobat di Rumah Sakit Rujukan Primer dan Faktor-Faktor yang Memengaruhi. J Penyakit Dalam Indones [Internet]. 2017 Sep 30 [cited 2022 Jan 27];4(3):123–7.
11. Ratnayake U, Kumanan T, Nadarajah RK. Factors Associated with Antihypertensive Medication Adherence among Diabetic Patients with Coexisting Hypertension in a Tertiary Care Centre from a Low Middle Income South Asian Country. J Patient Saf Qual Improv. 2021;9(1):29–39.
12. Dhar L, Dantas J, Ali M, Dhar L, Dantas J, Ali M. A Systematic Review of Factors Influencing Medication Adherence to Hypertension Treatment in Developing Countries. Open J Epidemiol [Internet]. 2017 Aug 8 [cited 2022 Jun 6];7(3):211–50.
13. Susanto A, Purwantiningrum H. Dukungan Keluarga dengan Pengetahuan dan Sikap pada Penderita Hipertensi. J Ilm Kesehat [Internet]. 2022 Apr 30 [cited 2022 Jun 6];4(1):81–9.
14. Indriana N, Tri Kumala Swandari M, Pertiwi Y. Hubungan Tingkat Pengetahuan Dengan Kepatuhan Minum Obat Pada Pasien Hipertensi Di Rumah Sakit X Cilacap. J Ilm JOPHUS J Pharm UMUS [Internet]. 2020 Jun 9 [cited 2022 Apr 12];2(01):1–10.
15. Notoatmodjo S. Promosi Kesehatan dan Perilaku Kesehatan. Jakarta: Rineka Cipta; 2012.
16. Getenet A, Tesfa M, Ferede A, Molla Y. Determinants of adherence to anti-hypertensive medications amongadult hypertensive patients on follow-up in Hawassa Referral Hospital: Acase–control study. JRSM Cardiovasc Dis [Internet]. 2019 Jan [cited 2022 May 9];8:204800401989275. Available from: /pmc/articles/PMC6967193/
17. Algabbani FM, Algabbani AM. Treatment adherence among patients with hypertension: findings from a cross-sectional study. Clin Hypertens 2020 261 [Internet]. 2020 Sep 15 [cited 2022 Jun 6];26(1):1–9.
18. Lee H, Yano Y, Cho SMJ, Heo JE, Kim DW, Park S, et al. Adherence to Antihypertensive Medication and Incident Cardiovascular Events in Young Adults with Hypertension. Hypertension [Internet]. 2021 [cited 2022 May 9];77:1341–9.
19. Brown MT, Bussell J, Dutta S, Davis K, Strong S, Mathew S. Medication Adherence: Truth and Consequences. Am J Med Sci [Internet]. 2016 Apr 1 [cited 2022 May 9];351(4):387–99.
20. Wahyuni AS, Mukhtar Z, Pakpahan DJR, Guhtama MA, Diansyah R, Situmorang NZ, et al. Adherence to Consuming Medication for Hypertension Patients at Primary Health Care in Medan City. Open Access Maced J Med Sci [Internet]. 2019 Oct 10 [cited 2022 Jun 6];7(20):3483.
21. Sekunda MS, Tokan PK, Owa K, Studi P, Ende K, Kupang K. Hubungan Faktor Predisposisi dengan Kepatuhan Pengobatan bagi Penderita Hipertensi. J Kesehat Prim [Internet]. 2021 May 31 [cited 2022 Jun 6];6(1):43–51.
22. Wahyudi CT, Ratnawati D, Made SA. Pengaruh Demografi, Psikososial, dan Lama Menderita Hipertensi Primer terhadap Kepatuhan Minum Obat Antihipertensi. J JKFT [Internet]. 2018 Mar 31 [cited 2022 Jun 6];2(2):14–28.
Copyright (c) 2023 Agus Susanto, Heni Purwantiningrum, Muhamad Muhamad Janadin Ass Saff
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.